Stocksigma LogoStocksigma Logo

Novyra Pharmachem Board Meeting Set for Q1 Results

Novyra Pharmachem Limited (BSE: 519353) has scheduled a Board of Directors meeting on 14th Aug'26. The primary agenda is to consider and approve the

Novyra Pharmachem Board Meeting Set for Q1 Results

Bansisons Tea Industries Ltd 路 Intimation 路 14 Aug 2026, 5:30 am

Novyra Pharmachem Board Meeting Set for Q1 Results Novyra Pharmachem Limited (BSE: 519353) has scheduled a Board of Directors meeting on 14th Aug'26. The primary agenda is to consider and approve the unaudited financial results for the first quarter ending 30th Jun'26. The results will be accompanied by the Auditor's Limited Review Report. The company was formerly known as Bansisons Tea Industries Ltd.

Original exchange filing (PDF)

More announcements from Bansisons Tea Industries Ltd

All Bansisons Tea Industries Ltd announcements